information

Whoever comes in this website may find a hint

Phage therapy is influenced by:

Phage therapy is influenced by:

Country :
the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view

From Wikipedia


If the target host* of a phage therapy treatment is not
an animal the term "
biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

"In silico"

From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.

Tuesday 29 July 2014

Mycobacterium ulcerans prophages


Most probably the idea to utilize Phage Therapy in human Buruli disease is impracticable at moment.

In the Net there is not any information about this but only one scientific work with mouse model.

In spite of everything I think it is useful to try all possibilities for exploring new forms of drugs in Buruli disease and among these also Phage therapy.

I quote the passages from :

Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer


".....771 pseudogenes, two bacteriophages, and multiple DNA deletions and rearrangements."

"The two prophages named phiMU01 (18 kb, 18 CDS) and phiMU02 (24 kb, 17 CDS) resemble other mycobacteriophages in overall structure, integrating near tRNA genes and containing CDS associated with replication functions. However, phiMU02 may be non-functional, as several of its genes have been inactivated by multiple IS2606 insertions."








"...and acquisition of foreign genes, often via plasmids or bacteriophage, that confer a fitness advantage in the new environment."

I want to check the passages quoted above because they are not described in details:

1° passage:

"The two prophages named phiMU01 (18 kb, 18 CDS) and phiMU02 (24 kb, 17 CDS) resemble other mycobacteriophages in overall structure, integrating near tRNA genes and containing CDS associated with replication functions."

In the beginning if these prophages were mycobacterium phages probably they have still some common features with other Mycobacterium phage genomes like D29,L5, BXZ2 and TM4.

2° passage:

"...phiMU02 may be non-functional, as several of its genes have been inactivated by multiple IS2606 insertions."


Checking by Gepard software

 phiMU01 versus phiMU01:
 
 


 phiMU02 versus phiMU02:


 
 explanation:



 By Mauve software and M-GCAT sofware the genomes are compared:

 phiMU01 versus phiMU02:










  alignment by JAligner



Now to shoot off :

a-
For avoiding misunderstandings I have written the words by WIKIPEDIA:

Prophage:
A prophage is a phage genome inserted as part of the linear structure of the DNA chromosome of a bacterium. A temperate phage integrated into the host chromosome or existing as an extrachromosomal plasmid. This is a latent form of a bacteriophage in which the viral genes are incorporated into the bacterial chromosomes without causing disruption of the bacterial cell.
Upon detection of host cell damage, the prophage is excised from the bacterial chromosome in a process called prophage induction. After induction, viral replication begins via the lytic cycle. Prophages are important agents of horizontal gene transfer, and are considered to be part of the mobilome.

Bacteriophage

b-phiMU01 and phiMU02 sequences are extracted from Mycobacterium ulcerans genome by Artemis software :

>misc_feature misc_feature Prophage phiMU01 523696:542119 forward
CCTTGCCGATAGACGGTACCGGCGCGCCCTGACGGGA
CGCGAACGATCAAGAAGCTACCCGCGCCGGTGTCGCT
GGACGGCACTCTAATAACGTCGCGGCTCGCTGGCGTT
GGAATTCAG..........AATC
>misc_feature misc_feature Prophage phiMU02 3582899:3606951 reverse
GTCAAGTGGTCGCAGGTTCAAATCCTGTCAGCCCGACCA
GAACGTTCTTACTCAAACCAGTGACCGAAAAGACACCGG
CCAAGGTGAGCGACTCCGTTCCGGTGGATCTAGGAGCC
CCTG......ACAT
c- each prophage genome is examined and compared with D29, L5,TM4 and BXZ2 genomes by Gepard software:


phiMU01 versus D29 phage :
 

 phiMU01, phiMU02 versus D29 phage:




The LCB weight sets the minimum number of matching nucleotides identified in a collinear region for that region to be considered true homology versus random similarity.

 phiMU01, phiMU02 versus Bxz2 phage:





 phiMU01, phiMU02 versus L5 phage:




 phiMU01, phiMU02 versus TM4 phage:



 all phages above:





Conclusions :

phiMU01 versus D29 phage



 all phages above:





This analysis reinforces my conviction about the presence in the soil , fresch water or in other sources of specific phages for Mycobacterium ulcerans. I am sure "nothing seek, nothing find".

phiMmar01


Why?

Mycobacterium ulcerans prophages



By Artemis :



By Mauve:


By Gepard :


phiMmar01/phiMmar01




phiMU01/phiMmar01




phiMU02/phiMmar01



MU and Mmar Prophages






Integrase Comparison


Going in search of phages for Mycobacterium ulcerans


This is my opinion about the question.

In practice at the moment I do not have the possibility to search phages for Mycobacterium ulcerans but, if I do not have real phages, however, I can study all potential phages (prophages) inside Mycobacterium marinum and Mycobacterium ulcerans genome.


1-If I find some correlations among "prophages" of these Mycobacteria I have further evidence that M. ulcerans is originated from M.marinum.

2-If I find some correlations between "prophages" of these Mycobacteria I have further evidence that specific phages for M. ulcerans and M.marinum could exist.



I quote the passage from:

Insights from the complete genome sequence of
Mycobacterium marinum on the evolution of Mycobacterium tuberculosis

"...and 10 putative prophages, named phiMmar01–10 (Supplemental Table 2)."




I will study these potential "prophages" one by one.

Monday 28 July 2014

Mycobacterium ulcerans by "In Silico" analysis. Step 3


*At last, here is the genome of Mycobacterium ulcerans

The genome presents the CDS and the respective sequences in amino acids.


*Go to DBGET Search Write Mycobacterium ulcerans
open and the page with information is showing.

In OMIM open NCBI for description and information on Mycobacterium ulcerans. In REFSEQ open NC005916 or [NCBI] and see Mycobacterium ulcerans AGY99 plasmid pMUM001, complete sequence.

*Now we know its genome ( 5.6 Mb chromosome ) and its 174,155-bp plasmid.

Mycobacterium ulcerans by "In Silico"analysis. Step 2


*It is possible to show the genome map of Mycobacterium ulcerans, example by Bacmap:


Open Bacmap

Choose letter M

Choose Mycobacterium ulceransOpen Map , now the genome map is showing.
Remember :
COGs
means Clusters of Orthologous Groups of proteins. 

The genome is divided in COGs ( groups of proteins with different action).

CDS is the coding sequence or the portion of a nucleotide sequence that makes up the triplet codons that actually code for amino acids.


*By BuruList it is possible to get a lot of information on Mycobacterium ulcerans genes:

write in the window Gene name: mlsA1
open and the page is showing


Remember :

contig is a Group of cloned (copied) pieces of DNA representing overlapping regions of a particular chromosome.

Mycobacterium ulcerans by "In Silico" analysis. Step 1


Go in HAMAP proteomes

select Mycobacterium ulcerans in the Proteome window and open the page.

The page shows:

Species: Mycobacterium ulcerans (strain Agy99)

Species code: MYCUA

Taxonomy
Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; Corynebacterineae; Mycobacteriaceae; Mycobacterium (TaxID: 362242) [NEWT/ NCBI]

Description

In 1948 the etiologic agent of the Bairnsdale ulcer in humans was discovered by a team of Australian researchers and was named Mycobacterium ulcerans. During the 1960s many cases were reported from the Buruli Country in Uganda and the disease became generally known as Buruli ulcer. The Buruli ulcer is a devastating necrotic disease of subcutaneous tissue and a single Buruli ulcer can cover more than 15% of a person's skin surface and contains huge numbers of extracellular bacteria. Despite their abundance and extensive tissue damage, there is no acute inflammatory response to the bacteria and the lesions are often painless. This pathology is attributed to mycolactone, a macrolide toxin. Impoverished rural communities of West and Central Africa are worst affected although the disease occurs in other parts of the world. Since 1989, the prevalence of Buruli ulcer has increased and now exceeds that of leprosy and, in some instances, tuberculosis. Outbreaks are sporadic and unpredictable. Although the epidemiology of Buruli ulcer is poorly understood, proximity to stagnant or slow-flowing watercourses is a recognized risk factor. M. ulcerans is associated with algae, therefore, snails and organisms that feed on algae could be passive hosts. It has been shown that M. ulcerans is able to multiply in the salivary glands of Naucoris cimicoides, a carnivorous water bug. Humans could become infected through contact with contaminated Naucorides. Mycobacterium ulcerans (strain Agy99) was isolated from an ulcerative lesion on the right elbow of a female patient from the Ga district of Ghana in 1999.


Its genome is made up of a 5.6 Mb chromosome and a 174,155-bp plasmid.


The chromosome contains 4160 CDS and 771 pseudogenes, it harbors two prophages, phiMU01 and phiMU02, 302 insertion sequence elements and multiple DNA deletions and rearrangements.


This indicates that M. ulcerans has recently evolved via lateral gene transfer and reductive evolution from the generalist, more rapid-growing environmental Mycobacterium marinum to become a niche-adapted specialist.


The virulence plasmid pMUM001 encodes 81 CDS. Six CDS code for proteins involved in mycolactone synthesis, among which, mlsA1 and mlsA2, two giant polyketide synthases (PKS) responsible for the synthesis of the mycolactone core, and mlsB which is responsible for the synthesis of the mycolactone side chain.


Properties:

Presence of flagella: No

Interaction: Animal pathogen in Mammalia

Number of membranes: 1

Number of inteins:0

Statistics: Number of MYCUA entries in the UniProt Knowledgebase: 4206 (320 in UniProtKB/Swiss-Prot + 3886 in UniProtKB/TrEMBL)


From this page select in the upper window: Swiss.Prot/TrEMBL and write Mycobacterium ulcerans , open and the list of genes is showing now.

In this page if you copy in Query window the name or the symbol of a gene: example mlsA1, the gene is showing now. If you open the specific code Q6MZA4
you obtain information on the relative protein.

Christus nobiscum.State

Motto:


1570: Ferrara  Earthquake





"CHRISTUS NOBISCUM.STATE" is an  invocation to God against the earthquakes and  in Italy it is written on the door jambs of some churchs or  carved on the medieval  bells.





 From"Paul's Cross and the Culture of Persuasion in England, 1520-1640"
by W.J.T. Kirby,P.G. Stanwood








The votive tablet on a door jamb:




Tuesday 22 July 2014

Buruli ulcer disease and the best stage for the therapy


The clinical feature of the pre-ulcerative stage of the disease are painless nodules, usually occurring singly on the legs or forearms and in theory they are the best target for all therapies.
Nodule
The lesion starts as a small subcutaneous swelling which is barely palpable but not visible. It gradually increases in size until the skin is slightly raised. The nodule is firm with a regular margin and is attached to skin but is not attached to the deep fascia.

As the lesion enlarges it involves the deep fascia and then extends in this layer . At this stage the edges are less distinct owing to an intervening layer of normal tissue. The skin overlying the lesion tends to desquamate,leaving a shiny surface which often appears darker than normal. Later the skin over the centre of the lesion loses its pigmentation, becomes necrotic, and eventually ulcerates. In some lesions a small central vesicle develops, which may be broken to exude a small amount of clear fluid. The burst vesicle may progress to an ulcer or it may heal.

BURULI: In this disease it is important to recognize the right moment for starting with a Phage Therapy treatment.




Top: Early nodular lesion.
Center/bottom:Deep and undermined ulcerative lesion with necrotic borders, before and after medical treatment plus local surgery including skin grafting.

This figure appears in color here

Are there Mycobacteriophages utilizable for Phage Therapy in Buruli ulcer?



Comment: I am happy about this work but not for mycobacteriophage choice. The same phages are used in all works with mycobacteria (the host range for D29 is very large and includes both slow and fast-growing species). This aspect ( this is my opinion) is not a favourable point for phage therapy in Buruli: we must wait  for a specific phage for Mycobacterium ulcerans strain that is isolated together in the same country.
This work supports the timeliness of phage therapy before the infection to become chronic (33 days) and confirms my working hypothesis: a, b, c



At the moment my answer to this question is negative.






Mostly well-known mycobacteriopages are isolated and multiplied by growth on Mycobacterium smegmatis lawn and are also lysogenic phages,
example:

Mycobacterium phage 244
Mycobacterium phage Adjutor
Mycobacterium phage Angel
Mycobacterium phage BPs
Mycobacterium phage Barnyard
Mycobacterium phage Bethlehem
Mycobacterium phage Boomer
Mycobacterium phage Brujita
Mycobacterium phage Butterscotch
Mycobacterium phage Bxb1
Mycobacterium phage Bxz1
Mycobacterium phage Bxz2
Mycobacterium phage Cali
Mycobacterium phage Catera
Mycobacterium phage Chah
Mycobacterium phage Che12
Mycobacterium phage Che8
Mycobacterium phage Che9c
Mycobacterium phage Che9d
Mycobacterium phage Cjw1
Mycobacterium phage Cooper
Mycobacterium phage Corndog
Mycobacterium phage D29
Mycobacterium phage DD5
Mycobacterium phage Fruitloop
Mycobacterium phage Giles
Mycobacterium phage Gumball
Mycobacterium phage Halo
Mycobacterium phage Jasper
Mycobacterium phage KBG
Mycobacterium phage Konstantine
Mycobacterium phage Kostya
Mycobacterium phage L5
Mycobacterium phage Llij
Mycobacterium phage Lockley
Mycobacterium phage Myrna
Mycobacterium phage Nigel
Mycobacterium phage Omega
Mycobacterium phage Orion
Mycobacterium phage PBI1
Mycobacterium phage PG1
Mycobacterium phage PLot
Mycobacterium phage PMC
Mycobacterium phage Pacc40
Mycobacterium phage Phaedrus
Mycobacterium phage Phlyer
Mycobacterium phage Pipefish
Mycobacterium phage Porky
Mycobacterium phage Predator
Mycobacterium phage Pukovnik
Mycobacterium phage Qyrzula
Mycobacterium phage Ramsey
Mycobacterium phage Rizal
Mycobacterium phage Rosebush
Mycobacterium phage ScottMcG
Mycobacterium phage Solon
Mycobacterium phage Spud
Mycobacterium phage TM4
Mycobacterium phage Troll4
Mycobacterium phage Tweety
Mycobacterium phage U2
Mycobacterium phage Wildcat



 
To find "genuine" lytic mycobacteriophages is not easy and it seems to me that it is also rare .

D29 is a lytic phage but I can not consider this phage
a "genuine " lytic phage by genome analysis.

These mycobacteriophages have a broad Host range and this feature is not favourable when they are used in Phage therapy.

I am of the opinion that Mycobacterium marinum may be the valid alternative to Mycobacterium smegmatis for growing and isolating phages with a potential action on Mycobacterium ulcerans but until now there is little information about growing phages on Mycobacterium marinum.

 

It is indispensable to work on
this virgin ground.

Monday 21 July 2014

In silico 2D-SDS-PAGE:M.marinum,M.ulcerans and M.smegmatis


In silico 2D-SDS-PAGE



Mycobacterium marinum
Proteome



Mycobacterium ulcerans Proteome




Mycobacterium smegmatis
Proteome



superimposing of pictures of Mycobacterium ulcerans Proteome with Mycobacterium marinum Proteome



superimposing of pictures
of Mycobacterium ulcerans
Proteome with Mycobacterium smegmatis Proteome